{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T22:55:45Z","timestamp":1769640945208,"version":"3.49.0"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T00:00:00Z","timestamp":1618876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803960"],"award-info":[{"award-number":["81803960"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"64th batch of postdoctoral general programs in China","award":["2018\u00a0M643723"],"award-info":[{"award-number":["2018\u00a0M643723"]}]},{"name":"National Science and Technology Major Project of China","award":["2019ZX09201004-001"],"award-info":[{"award-number":["2019ZX09201004-001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Targeting tumor microenvironment (TME), such as immune checkpoint blockade (ICB), has achieved increased overall response rates in many advanced cancers, such as non-small cell lung cancer (NSCLC), however, only in a fraction of patients. To improve the overall and durable response rates, combining other therapeutics, such as natural products, with ICB therapy is under investigation. Unfortunately, due to the lack of systematic methods to characterize the relationship between TME and ICB, development of rational immune-combination therapy is a critical challenge. Here, we proposed a systems pharmacology strategy to identify resistance regulators of PD-1\/PD-L1 blockade and develop its combinatorial drug by integrating multidimensional omics and pharmacological methods. First, a high-resolution TME cell atlas was inferred from bulk sequencing data by referring to a high-resolution single-cell data and was used to predict potential resistance regulators of PD-1\/PD-L1 blockade through TME stratification analysis. Second, to explore the drug targeting the resistance regulator, we carried out the large-scale target fishing and the network analysis between multi-target drug and the resistance regulator. Finally, we predicted and verified that oxymatrine significantly enhances the infiltration of CD8+ T cells into TME and is a powerful combination agent to enhance the therapeutic effect of anti-PD-L1 in a mouse model of lung adenocarcinoma. Overall, the systems pharmacology strategy offers a paradigm to identify combinatorial drugs for ICB therapy with a systems biology perspective of drug-target-pathway-TME phenotype-ICB combination.<\/jats:p>","DOI":"10.1093\/bib\/bbab130","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T12:09:19Z","timestamp":1616069359000},"source":"Crossref","is-referenced-by-count":12,"title":["Systems pharmacology: a combination strategy for improving efficacy of PD-1\/PD-L1 blockade"],"prefix":"10.1093","volume":"22","author":[{"given":"Chunli","family":"Zheng","sequence":"first","affiliation":[{"name":"Key Laboratory of Resource Biology and Biotechnology in Western China (Northwest University), Ministry of Education, School of Life Sciences, Northwest University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Xiao","sequence":"additional","affiliation":[{"name":"Key Laboratory of Resource Biology and Biotechnology in Western China (Northwest University), Ministry of Education, School of Life Sciences, Northwest University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuang","family":"Chen","sequence":"additional","affiliation":[{"name":"Guangxi Medical University cancer hospital, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinglin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Resource Biology and Biotechnology in Western China (Northwest University), Ministry of Education, School of Life Sciences, Northwest University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruijie","family":"Yang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Resource Biology and Biotechnology in Western China (Northwest University), Ministry of Education, School of Life Sciences, Northwest University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangna","family":"Yan","sequence":"additional","affiliation":[{"name":"Key Laboratory of Resource Biology and Biotechnology in Western China (Northwest University), Ministry of Education, School of Life Sciences, Northwest University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruifei","family":"Huang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Resource Biology and Biotechnology in Western China (Northwest University), Ministry of Education, School of Life Sciences, Northwest University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xiao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of New-tech for Chinese Medicine Pharmaceutical Process, Kanion Pharmaceutical Co. Ltd, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghua","family":"Wang","sequence":"additional","affiliation":[{"name":"Center of Bioinformatics, College of Life Sciences,Northwest A&F University and at Key Laboratory of Resource Biology and Biotechnology in Western China (Northwest University), Ministry of Education, School of Life Sciences, Northwest University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Huang","sequence":"additional","affiliation":[{"name":"Center of Bioinformatics, College of Life Sciences, Northwest A&F University and at Key Laboratory of Resource Biology and Biotechnology in Western China (Northwest University), Ministry of Education, School of Life Sciences, Northwest University, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,4,20]]},"reference":[{"key":"2021090814035650300_ref1","first-page":"228","article-title":"Target selection of CAR T cell therapy in accordance with the TME for solid tumors","volume":"9","author":"Liu","year":"2019","journal-title":"Am J Cancer Res"},{"key":"2021090814035650300_ref2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.intimp.2018.06.001","article-title":"Immune checkpoint blockade therapy for cancer: an overview of FDA-approved immune checkpoint inhibitors","volume":"62","author":"Hargadon","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"2021090814035650300_ref3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ccell.2018.03.005","article-title":"Emerging concepts for immune checkpoint blockade-based combination therapies","volume":"33","author":"Zappasodi","year":"2018","journal-title":"Cancer Cell"},{"key":"2021090814035650300_ref4","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1200\/JCO.2014.58.3708","article-title":"Overall survival and long-term safety of nivolumab (anti\u2013programmed death 1 antibody, BMS-936558, ONO-4538) in patients with previously treated advanced non\u2013small-cell lung cancer","volume":"33","author":"Gettinger","year":"2015","journal-title":"J Clin Oncol"},{"key":"2021090814035650300_ref5","first-page":"266","article-title":"ASCO 2018 NSCLC highlights\u2014combination therapy is key","volume-title":"Memo","author":"Gamerith","year":"2018"},{"key":"2021090814035650300_ref6","first-page":"87","article-title":"Natural products for lead identification: nature is a valuable resource for providing tools","volume":"93","author":"Grabley","year":"2003","journal-title":"EXS"},{"key":"2021090814035650300_ref7","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1039\/C7FO00595D","article-title":"Exploring the immunomodulatory and anticancer properties of zerumbone","volume":"8","author":"Haque","year":"2017","journal-title":"Food Funct"},{"key":"2021090814035650300_ref8","first-page":"710","article-title":"Systems pharmacology in drug discovery and therapeutic insight for herbal medicines","volume-title":"Brief Bioinform","author":"Huang","year":"2014"},{"key":"2021090814035650300_ref9","first-page":"153326","article-title":"Systems pharmacology unravels the synergic target space and therapeutic potential of Rhodiola rosea L. for non-small cell","volume":"79","author":"Zhang","year":"2020","journal-title":"Lung Cancer"},{"key":"2021090814035650300_ref10","first-page":"1473","article-title":"A novel systems pharmacology method to investigate molecular mechanisms of Scutellaria barbata D. don for non-small cell lung cancer","volume-title":"Front Pharmacol","author":"Liu","year":"2018"},{"key":"2021090814035650300_ref11","first-page":"969","article-title":"Systems pharmacology uncover the mechanism of anti-non-small cell lung cancer for Hedyotis diffusa Willd","volume-title":"Biomed Pharmacother","author":"Su","year":"2019"},{"key":"2021090814035650300_ref12","first-page":"1121","article-title":"Novel functions of herbal medicines in dendritic cells: role of Amomi semen in tumor immunity","volume-title":"Microbiol Immunol","author":"Fukui","year":"2007"},{"key":"2021090814035650300_ref13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.immuni.2018.03.007","article-title":"Combination cancer therapy with immune checkpoint blockade: mechanisms and strategies","volume":"48","author":"Patel","year":"2018","journal-title":"Immunity"},{"key":"2021090814035650300_ref14","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1007\/s11095-011-0467-9","article-title":"Systems pharmacology: bridging systems biology and pharmacokinetics-pharmacodynamics (PKPD) in drug discovery and development","volume":"28","author":"Van der Graaf","year":"2011","journal-title":"Pharm Res"},{"key":"2021090814035650300_ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6882-14-430","article-title":"A novel systems pharmacology model for herbal medicine injection: a case using reduning injection","volume":"14","author":"Yang","year":"2014","journal-title":"BMC Complement Altern Med"},{"key":"2021090814035650300_ref16","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.18632\/aging.202410","article-title":"Systems pharmacology dissection of Epimedium targeting tumor microenvironment to enhance cytotoxic T lymphocyte responses in lung cancer","volume":"13","author":"Huang","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"2021090814035650300_ref17","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s41591-018-0096-5","article-title":"Phenotype molding of stromal cells in the lung tumor microenvironment","volume":"24","author":"Lambrechts","year":"2018","journal-title":"Nat Med"},{"key":"2021090814035650300_ref18","first-page":"D721","article-title":"CellMarker: a manually curated resource of cell markers in human and mouse","volume-title":"Nucleic Acids Res","author":"Zhang","year":"2019"},{"key":"2021090814035650300_ref19","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baz046","article-title":"PanglaoDB: a web server for exploration of mouse and human single-cell RNA sequencing data","volume":"2019","author":"Franz\u00e9n","year":"2019","journal-title":"Database (Oxford)"},{"key":"2021090814035650300_ref20","doi-asserted-by":"publisher","DOI":"10.1101\/2020.01.07.897900","article-title":"Bayesian inference of cell composition and gene expression reveals tumor-microenvironment interactions","volume-title":"BioRxiv","author":"Chu","year":"2020"},{"key":"2021090814035650300_ref21","first-page":"2757","article-title":"Discovering causal pathways linking genomic events to transcriptional states using tied diffusion through interacting events (TieDIE)","volume-title":"Bioinformatics","author":"Paull","year":"2013"},{"key":"2021090814035650300_ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: implications for cancer immunotherapy","volume":"17","author":"Li","year":"2016","journal-title":"Genome Biol"},{"key":"2021090814035650300_ref23","first-page":"1","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines","volume-title":"J Cheminformatics","author":"Ru","year":"2014"},{"key":"2021090814035650300_ref24","first-page":"6964","article-title":"A novel chemometric method for the prediction of human oral bioavailability","volume-title":"Int J Mol Sci","author":"Xu","year":"2012"},{"key":"2021090814035650300_ref25","first-page":"i246","article-title":"Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework","volume-title":"Bioinformatics","author":"Yamanishi","year":"2010"},{"key":"2021090814035650300_ref26","first-page":"286","article-title":"Prediction of human intestinal absorption based on molecular indices","volume-title":"J Mol Sci","author":"Li","year":"2007"},{"key":"2021090814035650300_ref27","first-page":"1","article-title":"Large-scale direct targeting for drug repositioning and discovery","volume-title":"Sci Rep-UK","author":"Zheng","year":"2015"},{"key":"2021090814035650300_ref28","first-page":"e37608","article-title":"A systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological data","volume-title":"PLoS ONE","author":"Yu","year":"2012"},{"key":"2021090814035650300_ref29","first-page":"284","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume-title":"Omics","author":"Yu","year":"2012"},{"key":"2021090814035650300_ref30","first-page":"A68","article-title":"The cancer genome atlas (TCGA): an immeasurable source of knowledge","volume":"19","author":"Tomczak","year":"2015","journal-title":"Contemp Oncol (Pozn)"},{"key":"2021090814035650300_ref31","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.08.134270","article-title":"Spatially discrete signalling niches regulate fibroblast heterogeneity in human lung cancer","volume-title":"bioRxiv","author":"Hanley","year":"2020"},{"key":"2021090814035650300_ref32","first-page":"1","article-title":"Comprehensive analysis of the tumor immune micro-environment in non-small cell lung cancer for efficacy of checkpoint inhibitor","volume-title":"Sci Rep-UK","author":"Seo","year":"2018"},{"key":"2021090814035650300_ref33","first-page":"453","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume-title":"Nat Methods","author":"Newman","year":"2015"},{"key":"2021090814035650300_ref34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.celrep.2018.03.086","article-title":"Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images","volume":"23","author":"Saltz","year":"2018","journal-title":"Cell Rep"},{"key":"2021090814035650300_ref35","first-page":"2149","article-title":"B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders","volume-title":"Blood","author":"Wilcox","year":"2009"},{"key":"2021090814035650300_ref36","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1506824","article-title":"Dynamics of neutrophils-to-lymphocyte ratio predict outcomes of PD-1\/PD-L1 blockade","volume-title":"Biomed Res Int","author":"Moschetta","year":"2017"},{"key":"2021090814035650300_ref37","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa269","article-title":"CellTalkDB: a manually curated database of ligand\u2013receptor interactions in humans and mice","volume-title":"Brief Bioinform","author":"Shao","year":"2020"},{"key":"2021090814035650300_ref38","doi-asserted-by":"publisher","DOI":"10.1101\/507871","article-title":"iTALK: an R package to characterize and illustrate intercellular communication","volume-title":"bioRxiv","author":"Wang","year":"2019"},{"key":"2021090814035650300_ref39","first-page":"1","article-title":"A draft network of ligand\u2013receptor-mediated multicellular signalling in human","volume-title":"Nat Commun","author":"Ramilowski","year":"2015"},{"key":"2021090814035650300_ref40","first-page":"337","article-title":"Radix Sophorae flavescentis for chronic hepatitis B: a systematic review of randomized trials","volume-title":"Am J Chin Med","author":"Liu","year":"2003"},{"key":"2021090814035650300_ref41","first-page":"49","article-title":"Oxymatrine attenuates tumor growth and deactivates STAT5 signaling in a lung cancer xenograft model","volume-title":"Cancers","author":"Jung","year":"2019"},{"key":"2021090814035650300_ref42","first-page":"1","article-title":"Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs\/ROS\/Trx1 signalling pathway","volume-title":"J Exp Clin Canc Res","author":"Jin","year":"2018"},{"key":"2021090814035650300_ref43","first-page":"551","article-title":"A combination of a microemulsion and a phospholipid complex for topical delivery of oxymatrine","volume-title":"Arch Pharm Res","author":"Cao","year":"2011"},{"key":"2021090814035650300_ref44","article-title":"Oxymatrine exhibits anti-tumor activity in gastric cancer through inhibition of IL-21R-mediated JAK2\/STAT3 pathway","volume-title":"Int J Immunopath Ph","author":"Yanxia","year":"2018"},{"key":"2021090814035650300_ref45","doi-asserted-by":"crossref","DOI":"10.1007\/s10616-017-0153-9","article-title":"Oxymatrine induces apoptosis and inhibits invasion in gallbladder carcinoma via PTEN\/PI3K\/AKT pathway","volume-title":"Cytotechnology","author":"Qian","year":"2018"},{"key":"2021090814035650300_ref46","first-page":"63","article-title":"TGF-\u03b21 in tumor microenvironments induces immunosuppression in the tumors and sentinel lymph nodes and promotes tumor progression","volume-title":"J Immunother","author":"Nakamura","year":"2014"},{"key":"2021090814035650300_ref47","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/joim.12019","article-title":"VEGFA and tumour angiogenesis","volume":"273","author":"Claesson-Welsh","year":"2013","journal-title":"J Intern Med"},{"key":"2021090814035650300_ref48","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003183","article-title":"Medicinal herbs for hepatitis C virus infection","volume-title":"Cochrane Db Syst Rev","author":"Liu","year":"2001"},{"key":"2021090814035650300_ref49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-6-225","article-title":"Pathway level analysis of gene expression using singular value decomposition","volume":"6","author":"Tomfohr","year":"2005","journal-title":"BMC Bioinformatics"},{"key":"2021090814035650300_ref50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-Seq data","volume":"14","author":"Hnzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"2021090814035650300_ref51","first-page":"1","article-title":"Zebrafish as a potential model organism for drug test against hepatitis C Vireus","volume-title":"PLoS ONE","author":"Cun-Bao","year":"2011"},{"key":"2021090814035650300_ref52","first-page":"2480\u20133","article-title":"Oxymatrine therapy for chronic hepatitis B: a randomized double-blind and placebo-controlled multi-center trial","volume-title":"World J Gastroenterol","author":"Lu","year":"2003"},{"key":"2021090814035650300_ref53","first-page":"867","article-title":"Oxymatrine induces cell cycle arrest and apoptosis and suppresses the invasion of human glioblastoma cells through the EGFR\/PI3K\/Akt\/mTOR signaling pathway and STAT3","volume-title":"Oncol Rep","author":"Dai","year":"2018"},{"key":"2021090814035650300_ref54","first-page":"729","article-title":"Effect of oxymatrine on interferon-gamma and tumor necrosis factor-alpha serum levels in an experimental rat model of autoimmune encephalomyelitis","volume-title":"Neural Regen Res","author":"Guo","year":"2010"},{"key":"2021090814035650300_ref55","first-page":"558","article-title":"Protective effects of oxymatrine on vascular endothelial cells from high-glucose-induced cytotoxicity by inhibiting the expression of A2B receptor","volume-title":"Cell Physiol Biochem","author":"Yi","year":"2018"},{"key":"2021090814035650300_ref56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"2021090814035650300_ref57","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"key":"2021090814035650300_ref58","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3389\/fimmu.2018.00711","article-title":"Targeting cytosolic nucleic acid-sensing pathways for cancer immunotherapies","volume":"9","author":"Sandra","year":"2018","journal-title":"Front Immunol"},{"key":"2021090814035650300_ref59","first-page":"974","article-title":"Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses","volume-title":"Cell","author":"Katherine","year":"2015"},{"key":"2021090814035650300_ref60","first-page":"549","article-title":"LSD1 ablation stimulates anti-tumor immunity and enables checkpoint blockade","volume-title":"Cell","author":"Sheng","year":"2018"},{"key":"2021090814035650300_ref61","first-page":"1147","article-title":"Switching roles for DNA and histone methylation depend on evolutionary ages of human endogenous retroviruses","volume-title":"Genome Res","author":"Ohtani","year":"2018"},{"key":"2021090814035650300_ref62","first-page":"11","article-title":"Effect of oxymatrine on interferon-gamma and tumor necrosis factor-alpha serum levels in an experimental rat model of autoimmune encephalomyelitis","volume":"10","year":"2010","journal-title":"J Neural Regeneration Research"},{"key":"2021090814035650300_ref63","first-page":"61","article-title":"Activation of NF-\u03baB by double-stranded RNA (dsRNA) in the absence of protein kinase R and RNase L demonstrates the existence of two separate dsRNA-triggered antiviral programs","volume-title":"Mol Cell Biol","author":"Iordanov","year":"2001"},{"key":"2021090814035650300_ref64","first-page":"352","article-title":"The gene expression profiles in response to 102 traditional Chinese medicine (TCM) components: a general template for research on TCMs","author":"Lv","year":"2017"},{"key":"2021090814035650300_ref65","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/ng.3593","article-title":"Functional characterization of somatic mutations in cancer using network-based inference of protein activity","volume":"48","author":"Alvarez","year":"2016","journal-title":"Nat Genet"},{"key":"2021090814035650300_ref66","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1093\/bioinformatics\/btw216","article-title":"ARACNe-AP: gene network reverse engineering through adaptive partitioning inference of mutual information","volume":"32","author":"Lachmann","year":"2016","journal-title":"Bioinformatics"},{"key":"2021090814035650300_ref67","first-page":"3167\u201375","article-title":"Phase I study of single-agent anti\u2013programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates","volume-title":"J Clin Oncol","author":"Brahmer","year":"2010"},{"key":"2021090814035650300_ref68","first-page":"2455","article-title":"Safety and activity of anti\u2013PD-L1 antibody in patients with advanced cancer","volume-title":"N Engl J Med","author":"Brahmer","year":"2012"},{"key":"2021090814035650300_ref69","first-page":"134","article-title":"Safety and tumor responses with lambrolizumab (anti\u2013PD-1) in melanoma","volume-title":"N Engl J Med","author":"Hamid","year":"2013"},{"key":"2021090814035650300_ref70","first-page":"5458","article-title":"Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade","volume-title":"Cancer Res","author":"Dovedi","year":"2014"},{"key":"2021090814035650300_ref71","first-page":"e108","article-title":"TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells","volume-title":"Cancer Res","author":"Li","year":"2017"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/5\/bbab130\/40260895\/bbab130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/bib\/article-pdf\/22\/5\/bbab130\/40260895\/bbab130.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T15:03:05Z","timestamp":1631113385000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbab130\/6238586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,20]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9,2]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbab130","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9]]},"published":{"date-parts":[[2021,4,20]]},"article-number":"bbab130"}}